Keyphrases
Hepatocellular Carcinoma
100%
Inactivator
100%
Ornithine Aminotransferase
100%
Tumor Inhibition
22%
Clinical Trials
11%
Monoclonal Antibody
11%
Effective Treatment
11%
Catenin
11%
Mechanistic Studies
11%
FDA-approved Drugs
11%
Cancer Causes
11%
Cancer Mortality
11%
Inactivation Mechanism
11%
Tyrosine Kinase Inhibitor
11%
GABA-AT
11%
Mechanism-based Inactivation
11%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Ornithine Oxoacid Aminotransferase
100%
Cancer Inhibition
22%
Preclinical Study
11%
Clinical Trial
11%
4 Aminobutyric Acid
11%
Catenin
11%
Protein Tyrosine Kinase Inhibitor
11%
Cancer Mortality
11%
Monoclonal Antibody
11%